New lateral flow tests are being sent out in Wales and you need to do them differently. If you order tests to your home you may soon see a different style test arrive than you've become used to. The ...

Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. As the coronavirus pandemic continues ...

The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...

Lateral flow tests (LFTs) became a slightly uncomfortable but necessary part of our lives since the onset of the Covid-19 pandemic. Most of us will have wiped swabs inside our nostrils and swirled ...

Editor's Note: Article updated with latest information on availability of tests. People faced problems getting hold of the tests last week after a huge surge in demand prompted the Government website ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Lateral flow assays have evolved rapidly over the last 30 years, and are routinely used for point-of-care and companion diagnostic applications. Technology advances have been the driving force behind ...

Polymerase chain reaction (PCR) tests were the first available for spotting the coronavirus. They work by detecting the virus’s genetic material, and are very accurate. Then came rapid tests, also ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

More than 14 million coronavirus tests have been taken in the UK in the past year, of which around 60% were polymerase chain reaction (PCR) tests, according to government data. But the use of lateral ...

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...